Non-alcoholic fatty liver (NAFLD) is the most common chronic liver disorder increasing morbidity and mortality worldwide with cardiovascular disease (CVD) being the main cause of death.¹ Recent findings from a meta-analysis of observational studies demonstrated an increased cardiovascular risk with NAFLD, especially with advanced fibrosis.² Therefore, with several studies highlighting this association, it may be important to consider cardiovascular screening in NAFLD patients in addition to the management of liver disease due to its potential in decreasing the disease burden.³

Gastrostomy tubes (G-tubes) are instrumental devices frequently used in the palliative care for patients with end-stage cancers.^1-3 Despite their routine utilization, there is a gap in the scientific literature of their efficacy, placement and clinical outcomes.¹ Recent findings published in the Journal of the National Comprehensive Cancer Network suggest that G-tubes, employed for enteral nutrition and gastric decompression, play a salient role in the palliation for a mixed population of patients with cancers.¹ Additional findings show that patients who received palliative care and/or social work consults resulted in higher frequency for hospice, suggesting their impact on the decision-making processes for cancer patients.¹